FDA Approves Eugenol Sedative for Field Use in Freshwater Finfish

If your email program has trouble displaying this email, view as a webpage.

US Food and Drug Administration

FDA Approves Eugenol Sedative for Field Use in Freshwater Finfish

August 25, 2026 

The U.S. Food and Drug Administration today approved AQUI-S E10% (eugenol immersion solution) for the sedation of freshwater finfish to a handleable condition. AQUI-S E10% is approved for field-use only, which means it is for use in wild fish populations not in aquaculture or hatchery settings. The product is intended to sedate fish for safe handling during resource management activities such as spawning, tagging, weighing, and measuring.  

AQUI-S E10% is administered as a static immersion bath, in which fish are placed into a container of water with the solution and removed once they are sedated to a handleable condition.

Read More Button


You are subscribed to updates from FDA's Center for Veterinary Medicine.


This email was sent to Esdek@podam.pl using Granicus Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo